Jim Beam plans to ramp up bourbon production at its largest Kentucky distillery to meet growing global demand in a more than $400 million expansion to be powered by renewable energy. The project will ...
Highest priority programs – BEAM-101 and ESCAPE for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency – expected to provide foundation for meaningful value creation Company to ...
Beam Therapeutics (NASDAQ:BEAM) said it plans to cut approximately 20% of its workforce, or around 100 jobs, as part of a corporate restructuring initiative. As a result of the layoffs, which are ...
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Beam Therapeutics (NasdaqGS:BEAM) launched BEAM-304, a new ...
KENTUCKY, USA — Jim Beam plans to ramp up bourbon production at its largest Kentucky distillery to meet growing global demand in a more than $400 million expansion to be powered by renewable energy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results